New Delhi, Mar 27 (PTI) Dr Reddy's Laboratories on Wednesday said it has entered into an exclusive partnership with Sanofi Healthcare India to promote and distribute the latter's vaccine brands in India.

Under the arrangement, Dr Reddy's will have exclusive rights to promote and distribute Sanofi's paediatric and adult vaccine brands Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U, the Hyderabad-based drug major said in a statement.

Also Read | Francis Scott Key Bridge Collapse in Baltimore: Things to Know About Key Bridge aka Beltway Bridge in the US That Collapsed Into River After Being Struck by Cargo Ship.

These brands saw combined sales of around Rs 426 crore as per IQVIA MAT February 2024 data.

Sanofi will continue to own, manufacture, and import these brands to the country.

Also Read | Shaheed Diwas 2024 Date in India: Know History and Significance of the Day That Commemorates Death Anniversary of Bhagat Singh, Sukhdev and Rajguru.

"The portfolio now gives Dr Reddy's a strong presence in the vaccine segment, propelling us to the second position among vaccine players in India. Through each product and partnership, our aim is to serve over 1.5 billion patients by 2030," Dr Reddy's CEO Branded Markets (India and Emerging Markets) MV Ramana said.

Sanofi General Manager India for Vaccines Preeti Futnani said: "To fulfil our long-term commitment to India and expand our geographic reach, we're pleased to partner with Dr Reddy's Laboratories."

The company is confident that this partnership will further bolster the promise of saving millions of lives against vaccines-preventable diseases with improved vaccination coverage, she added.

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)